John M. Vernon

5.7k total citations · 1 hit paper
107 papers, 3.4k citations indexed

About

John M. Vernon is a scholar working on Organic Chemistry, Economics and Econometrics and Management of Technology and Innovation. According to data from OpenAlex, John M. Vernon has authored 107 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Organic Chemistry, 25 papers in Economics and Econometrics and 15 papers in Management of Technology and Innovation. Recurrent topics in John M. Vernon's work include Pharmaceutical Economics and Policy (19 papers), Intellectual Property and Patents (15 papers) and Synthesis and pharmacology of benzodiazepine derivatives (15 papers). John M. Vernon is often cited by papers focused on Pharmaceutical Economics and Policy (19 papers), Intellectual Property and Patents (15 papers) and Synthesis and pharmacology of benzodiazepine derivatives (15 papers). John M. Vernon collaborates with scholars based in United States, United Kingdom and Germany. John M. Vernon's co-authors include Henry G. Grabowski, Joseph E. Harrington, W. Kip Viscusi, Joseph A. DiMasi, Daniel A. Graham, Abood A. Bahajaj, Lacy Glenn Thomas, R. M. Acheson, Gregory J. Hitchings and M. H. Moore and has published in prestigious journals such as The Journal of Finance, American Economic Review and The Quarterly Journal of Economics.

In The Last Decade

John M. Vernon

103 papers receiving 2.9k citations

Hit Papers

Economics of regulation and antitrust 1992 2026 2003 2014 1992 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John M. Vernon United States 28 2.0k 682 649 601 389 107 3.4k
Peter Swann United Kingdom 39 2.2k 1.1× 267 0.4× 762 1.2× 1.8k 3.1× 99 0.3× 99 7.8k
Ashok K. Gupta India 33 309 0.2× 432 0.6× 799 1.2× 2.0k 3.4× 34 0.1× 146 4.7k
Frank Hahn United Kingdom 38 4.0k 2.0× 386 0.6× 38 0.1× 253 0.4× 31 0.1× 149 6.2k
Michael Hay United States 25 259 0.1× 754 1.1× 1.1k 1.7× 222 0.4× 30 0.1× 54 2.9k
Henk de Vries Netherlands 35 240 0.1× 406 0.6× 261 0.4× 932 1.6× 38 0.1× 197 4.0k
Ralph Landau United States 16 744 0.4× 142 0.2× 300 0.5× 500 0.8× 8 0.0× 39 1.8k
Thomas J. Holmes United States 24 4.4k 2.2× 47 0.1× 307 0.5× 828 1.4× 16 0.0× 67 5.8k
Laura Magazzini Italy 10 625 0.3× 32 0.0× 367 0.6× 260 0.4× 75 0.2× 21 1.3k
Yong S. Lee United States 17 345 0.2× 124 0.2× 514 0.8× 579 1.0× 13 0.0× 32 1.8k
Pedro S. Coelho Portugal 29 131 0.1× 1.1k 1.7× 72 0.1× 448 0.7× 288 0.7× 69 4.7k

Countries citing papers authored by John M. Vernon

Since Specialization
Citations

This map shows the geographic impact of John M. Vernon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Vernon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Vernon more than expected).

Fields of papers citing papers by John M. Vernon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Vernon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Vernon. The network helps show where John M. Vernon may publish in the future.

Co-authorship network of co-authors of John M. Vernon

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Vernon. A scholar is included among the top collaborators of John M. Vernon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Vernon. John M. Vernon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grabowski, Henry G. & John M. Vernon. (2016). Consumer Product Safety Regulation. American Economic Review. 68(2). 284–289.
3.
Grabowski, Henry G., John M. Vernon, & Joseph A. DiMasi. (2002). RETURNS ON R&D FOR 1990s NEW DRUG INTRODUCTIONS. PharmacoEconomics. 20. 6 indexed citations
4.
Grabowski, Henry G., John M. Vernon, & Joseph A. DiMasi. (2002). Returns on Research and Development for 1990s New Drug Introductions. PharmacoEconomics. 20(Supplement 3). 11–29. 191 indexed citations
5.
Grabowski, Henry G. & John M. Vernon. (2000). The Distribution of Sales Revenues from Pharmaceutical Innovation. PharmacoEconomics. 18(Supplement 1). 21–32. 39 indexed citations
6.
Grabowski, Henry G. & John M. Vernon. (1997). Longer Patents for Increased Generic Competition: the Waxman-Hatch Act after One Decade. SSRN Electronic Journal. 14 indexed citations
7.
Grabowski, Henry G. & John M. Vernon. (1994). Returns to R&D on new drug introductions in the 1980s. Journal of Health Economics. 13(4). 383–406. 127 indexed citations
8.
Bailey, Patrick D., Ian D. Collier, Sean P. Hollinshead, et al.. (1994). A new asymmetric route to bridged indole alkaloids: formal syntheses of (–)-suaveoline, (–)-raumacline and (–)-Nb-methylraumacline. Journal of the Chemical Society Chemical Communications. 1559–1560. 10 indexed citations
9.
Graham, Daniel A. & John M. Vernon. (1991). A Note on Decentralized Natural Monopoly Regulation. Southern Economic Journal. 58(1). 273–273. 2 indexed citations
10.
Grabowski, Henry G. & John M. Vernon. (1990). A New Look at the Returns and Risks to Pharmaceutical R&D. Management Science. 36(7). 804–821. 208 indexed citations
11.
Hitchings, Gregory J. & John M. Vernon. (1990). Regioselective formation of hydroxy lactams from pyridine-2,3-dicarboximides and their cyclodehydration to pyrido[2′,3′:3,4]pyrrolo-fused heterocyclic systems. Journal of the Chemical Society Perkin Transactions 1. 1757–1763. 27 indexed citations
12.
Vernon, John M.. (1987). Longer patents for lower imitation barriers: The 1984 Drug Act. Journal of Product Innovation Management. 4(3). 235–235. 58 indexed citations
13.
Grabowski, Henry G. & John M. Vernon. (1979). Substitution laws and innovation in the pharmaceutical industry.. Law and Contemporary Problems. 43(1). 43–66. 13 indexed citations
14.
Vernon, John M.. (1977). Consumer Protection Regulation in Ethical Drugs. American Economic Review. 67(1). 359–364. 20 indexed citations
15.
Graham, Daniel A. & John M. Vernon. (1975). The Economics of the Network-Affiliate Relationship. American Economic Review. 65(5). 1033–1036. 1 indexed citations
16.
Vernon, John M., et al.. (1972). Profitability and market structure : an analysis of major manufacturers of non-durable consumer products. Marketing Science Institute eBooks. 1 indexed citations
17.
Vernon, John M.. (1972). Market structure and industrial performance : a review of statistical findings. Allyn and Bacon eBooks. 34 indexed citations
18.
Vernon, John M. & Marjorie B. McElroy. (1972). A note on estimation in market structure-performance studies. Marketing Science Institute eBooks. 3 indexed citations
19.
Thomas, C. Barry, et al.. (1971). The mass spectra of nitrophenyl(phenyl)methanes: the formation of an M–17 ion from the meta- and para-isomers. Journal of the Chemical Society B Physical Organic. 0(0). 1273–1282. 9 indexed citations
20.
Huisgen, Rolf, et al.. (1965). 1.3‐Dipolare Cycloadditionen, XXII. Zur Anlagerung organischer Azide an winkelgespannte Doppelbindungen. Chemische Berichte. 98(12). 3992–4013. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026